J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

J&J's revenue of $24.8 billion rose 10.8%, mostly driven by $1.82 billion in international sales of its Covid vaccine.

from Health and Science https://ift.tt/3qXcY5g
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH